investorscraft@gmail.com

Intrinsic ValueTotally plc (TLY.L)

Previous Close£0.24
Intrinsic Value
Upside potential
Previous Close
£0.24

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Totally plc operates as a provider of out-of-hospital healthcare services in the UK and Ireland, structured across three segments: Urgent Care, Planned Care, and Insourcing. The company delivers specialized treatments such as physiotherapy, podiatry, and dermatology, primarily serving NHS patients while also catering to corporate and private clients with occupational health and ergonomic services. Its diversified service portfolio includes clinical health coaching for chronic conditions and IT healthcare solutions, positioning it as an integrated healthcare facilitator. Totally plc distinguishes itself through a hybrid model that combines public sector contracts with private sector engagements, enhancing its resilience against NHS funding fluctuations. The company’s focus on musculoskeletal and dermatological care aligns with growing demand for non-hospital treatments, supported by its insourcing segment that aids NHS backlogs. Despite operating in a competitive landscape dominated by larger providers, Totally plc maintains a niche presence through localized service delivery and partnerships with NHS trusts.

Revenue Profitability And Efficiency

Totally plc reported revenue of £106.7 million for FY 2024, reflecting its scale in the out-of-hospital healthcare market. However, the company recorded a net loss of £3.1 million, with diluted EPS of -1.6p, indicating profitability challenges. Operating cash flow was negative at £664k, exacerbated by capital expenditures of £636k, suggesting strained liquidity amid operational investments.

Earnings Power And Capital Efficiency

The company’s negative earnings and cash flow underscore inefficiencies in converting revenue to profitability. With no dividend payouts and a focus on service expansion, capital allocation appears geared toward growth rather than immediate shareholder returns. The modest market cap of £5.9 million implies limited earnings power relative to peers.

Balance Sheet And Financial Health

Totally plc holds £2.3 million in cash against £5.0 million in total debt, indicating a leveraged position with constrained liquidity. The absence of dividends aligns with its focus on debt management and operational sustainability, though the negative cash flow raises concerns about near-term financial flexibility.

Growth Trends And Dividend Policy

Growth is driven by NHS partnerships and insourcing demand, but profitability remains elusive. The company has not issued dividends, prioritizing reinvestment in service lines. The lack of positive EPS trends suggests challenges in scaling profitably despite revenue generation.

Valuation And Market Expectations

The stock’s low beta (0.35) reflects muted volatility, likely due to its small-cap status and niche market. The negative earnings and cash flow metrics suggest the market discounts its near-term prospects, with valuation primarily tied to revenue multiples rather than profitability.

Strategic Advantages And Outlook

Totally plc’s hybrid public-private model and NHS collaborations provide stability, but profitability hinges on cost management and contract scalability. The outlook remains cautious given operational cash burn, though its niche services could benefit from long-term healthcare decentralization trends.

Sources

Company filings, London Stock Exchange data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount